Despite their potential for toxicity, NMDA receptor antagonists have therapeutic benefits. Ketamine, for instance, is used as an anesthetic and for treatment-resistant depression. Memantine is employed in Alzheimer's disease management to slow cognitive decline. These therapeutic uses highlight the delicate balance between the benefits and risks of NMDA receptor antagonists, emphasizing the importance of controlled and supervised usage.
